CW
RXRX icon

CreativeOne Wealth’s Recursion Pharmaceuticals RXRX Stock Holding History

CreativeOne Wealth’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,935
Closed -$100K – 1175
2025
Q1 		$100K Buy
18,935
+567
+3% +$4.13K ﹤0.01% 1032
2024
Q4 		$124K Buy
+18,368
New +$123K ﹤0.01% 1036

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

CreativeOne Wealth's RXRX Position: Q2 2025 in Review

CreativeOne Wealth sold out of Recursion Pharmaceuticals (RXRX) in Q2 2025, closing a stake of 18,935 shares — an estimated $100K sold.

CreativeOne Wealth first reported a position in RXRX in Q4 2024 and held it in 2 quarters. The position peaked at $124K in Q4 2024. 332 funds tracked by Wall St. Rank hold RXRX as of Q2 2025.

  • CreativeOne Wealth reported no remaining Recursion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • CreativeOne Wealth sold 18,935 Recursion Pharmaceuticals shares in Q2 2025, an estimated $100K.
  • CreativeOne Wealth first reported a position in Recursion Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • CreativeOne Wealth's Recursion Pharmaceuticals position peaked at $124K in Q4 2024.
  • 332 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2025.

Based on CreativeOne Wealth's 13F filing for Q2 2025, filed 12 Aug 2025.